Product Reports Resources Pricing Login Book a demo

Invuity

Health Tech & Medtech · San Francisco, United States · Founded 2004 · IPO 2015

Invuity, Inc. operated as a medical technology company, establishing a notable presence in the advanced surgical devices market before its acquisition. Founded in 2004 by Alex Vayser and headquartered in San Francisco, California, the firm focused on enhancing surgical procedures through superior visualization. The company's core offering was its patented Intelligent Photonics technology, a sophisticated system designed to illuminate surgical cavities during minimally invasive operations. This technology utilized proprietary optical waveguides to provide broad, uniform, and thermally cool light, enabling surgeons to work with greater precision, safety, and efficiency, particularly in deep and dark surgical sites. The business model centered on the development and sale of single-use, lighted surgical instruments. Its product portfolio included a variety of retractors, handheld devices, and drop-in illuminators. These tools were applied across a wide range of clinical specialties, including orthopedic and spine surgery, gynecology, breast cancer and reconstructive surgery, thyroid procedures, and general surgery. The company's clients were primarily hospitals and surgeons who perceived the products as differentiated, allowing Invuity to command premium pricing. The firm went public in June 2015 and had raised a total of $99.1 million in funding over several rounds from investors such as HealthCare Royalty Partners, Wellington, and Valence Life Sciences. A significant milestone in the company's history was its acquisition by Stryker Corporation. The definitive agreement was announced in September 2018, with Stryker acquiring all outstanding shares of Invuity for approximately $190 million. The acquisition was completed in October 2018, after which Invuity became a wholly-owned subsidiary of Stryker and its shares were delisted from NASDAQ. The move was seen as highly complementary to Stryker's instruments business, combining its leadership in minimal access surgery with Invuity's visualization technology to improve patient outcomes and operating room efficiencies. Keywords: surgical visualization, medical photonics, minimal access surgery, lighted surgical instruments, surgical devices, intelligent photonics, surgical retractors, operating room efficiency, surgical safety, medical technology, Stryker acquisition, orthopedic surgery, spine surgery, women's health surgery, breast reconstruction, single-use medical devices, advanced surgical devices, surgical illumination, direct visualization, medtech

Valuation $0–100M
Revenue $10–50M
Total funding $100–500M

Investors

6 investors on Invuity's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 5 investors entered at this stage
Valence Life Sciences
InterWest Partners
Wexford Capital
HealthCare Royalty
Wellington Management

Global footprint

Where Invuity has talent and traffic

Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Talent graph

The shape of Invuity's talent

Dealroom maps Invuity's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

12 team members profilednamed & role-tagged by Dealroom
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Invuity's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Invuity

An AI-synthesized read of the highest-engagement posts about Invuity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Invuity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.